Newsroom
Sorted by: Latest
-
Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026. The AGM, held in Paris on May 21, 2026, adopted all the resolutions regarding the approval of the Company’s financial statements, the granting of financial d...
-
Advicenne annonce une évolution de sa gouvernance à l’issue de son Assemblée Générale Mixte du 21 mai 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce une évolution de sa gouvernance à l’issue de son Assemblée Générale Mixte du 21 mai 2026. L’Assemblée Générale Mixte des actionnaires, réunie à Paris le 21 mai 2026, a adopté l’ensemble des résolutions proposées au vote relatives à...
-
Motorola Solutions Opens New AI and Resilience Software Hub in Boston, Massachusetts
BOSTON--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today announced the opening of its new AI and resilience software hub in Boston, Massachusetts. The hub serves as a key research and development site for applied AI and mission-critical, cloud-based solutions, powering the core platform that enables seamless emergency coordination and collaboration between private enterprises and first responders. Thousands of K-12 schools and higher education institutions rely on this platform to manage c...
-
Mizuho Financial Group Launches Strategic Technology and Operations Center in Pune
PUNE, India--(BUSINESS WIRE)--Mizuho Global Services India Pvt. Ltd., the Global Capabilities Center arm (Mizuho GCC) of Mizuho Financial Group, one of the world’s leading financial institutions, today announced the launch of its new Global Capabilities Center in Pune, India (Pune GCC). The center has been established to strengthen Mizuho’s global technology, operations, and shared services capabilities, supporting Mizuho’s enterprise-wide innovation, resilience, and long‑term transformation ag...
-
HAYA Therapeutics annonce l’administration du traitement à la première cohorte dans le cadre de l’essai clinique de phase 1 sur HTX-001, un traitement expérimental de précision visant la reprogrammation cellulaire destiné à la fibrose cardiaque
LAUSANNE, Suisse et SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics SA, une société de biotechnologie de précision de stade clinique qui développe des thérapies innovantes, programmables et guidées par l’ARN ciblant le génome régulateur afin de reprogrammer les états cellulaires pathologiques dans les maladies courantes, chroniques et liées à l’âge, a annoncé que la première cohorte avait été recrutée et avait reçu une première administration dans le cadre de l’essai clinique de phase 1 mené par...
-
Cushman & Wakefield Arranges $74.1 Million Financing for Bank of Italy Office-to-Residential Conversion in Downtown San Jose
NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a global real estate services firm, announced that it has arranged $74.1 million in financing on behalf of the Silicon Valley Initiative Partnership for the conversion of the historic Bank of Italy building at 12 South 1st Street in downtown San Jose, California. The financing was provided by Deutsche Bank. The project involves the adaptive reuse of the iconic Bank of Italy building, transforming the 13-story historic office tower...
-
HAYA Therapeutics gibt Dosierung der ersten Kohorte in Phase-1-Studie zu HTX-001 bekannt, einem Prüfpräparat zur gezielten zellulären Reprogrammierung bei Herzfibrose
LAUSANNE, Schweiz, und SAN DIEGO, Kalifornien, USA--(BUSINESS WIRE)--HAYA Therapeutics SA, ein klinisches Biotech-Unternehmen und Wegbereiter im Bereich präzisionsmedizinischer RNA-geführter Therapeutika, gab heute bekannt, dass die erste Kohorte in der klinischen Phase-1-Studie des Unternehmens zur Untersuchung von HTX-001 vollständig aufgenommen und dosiert wurde. Die Therapeutika von HAYA zielen auf das regulatorische Genom ab, um krankheitsfördernde Zellzustände bei häufigen, chronischen un...
-
Inszone Insurance Services Acquires Legacy Partners Insurance Services, Strengthening Footprint in Southeast Michigan
SACRAMENTO, Calif.--(BUSINESS WIRE)--Inszone Insurance Services, a rapidly growing national provider of commercial, personal, and benefits insurance, is pleased to announce the acquisition of Legacy Partners Insurance Services. This strategic acquisition further solidifies Inszone's presence in the Midwest, bringing a highly respected, "one-stop shop" agency into the Inszone family. Founded in 2013 by Joe Graham, Legacy Partners has spent the last decade growing exponentially throughout Southea...
-
Symetra Wins 2026 Shorty Award for ‘Plan Well, Play Well’ Social Media Campaign with Sue Bird
BELLEVUE, Wash.--(BUSINESS WIRE)--Symetra received a 2026 Shorty Award for its “Plan Well, Play Well” social content campaign, winning in the Insurance category....
-
Kraft Heinz Announces Pricing Terms and the Accepted Tender Amounts for the Cash Tender Offer for Up To $1.1 Billion Aggregate Purchase Price of Certain of Its Outstanding Notes
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (“Kraft Heinz”) (Nasdaq: KHC) announced today the pricing terms and the accepted tender amounts in respect of the previously announced offer by Kraft Heinz Foods Company, its 100% owned subsidiary (the “Issuer”), to purchase for cash (the “Tender Offer”) up to the maximum combined aggregate purchase price of $1,100,000,000, excluding accrued and unpaid interest (the “Maximum Tender Amount”), of its outstanding 4.375% Senior Notes du...